Suchergebnisse - "Rodon, Jordi"

PubPharm (406)

1

Plitidepsin as an Immunomodulator against Respiratory Viral Infections

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2024

von Losada, A. | Izquierdo-Useros, N. | Aviles, P. | +21

2

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

enthalten in: The oncologist | 2024

von Piha-Paul, S. | Xu, B. | Dumbrava, E. | +22

3

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 and golden Syrian hamster upon SARS-CoV-2 infection.

enthalten in: ResearchSquare.com | 2024

von Carrillo, J. | Ávila-Nieto, C. | Vergara-Alert, J. | +30

4

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

enthalten in: Nature communications | 2024

von Ávila-Nieto, C. | Vergara-Alert, J. | Amengual-Rigo, P. | +30

5

Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023

enthalten in: Emerging infectious diseases | 2024

von Ogoti, B. | Riitho, V. | Wildemann, J. | +13

6

A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors

enthalten in: Cancers | 2024

von Janku, F. | Choong, G. | Opyrchal, M. | +12

7

A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer

enthalten in: Breast cancer research : BCR | 2024

von Rodón, J. | Demanse, D. | Rugo, H. | +9

8

Middle East respiratory coronavirus (MERS-CoV) internalized by llama alveolar macrophages does not result in virus replication or induction of pro-inflammatory cytokines

enthalten in: Microbes and infection | 2024

von Rodon, J. | Sachse, M. | Te, N. | +4

9

Co-Clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts

enthalten in: Cancer discovery | 2024

von DiPeri, T. | Evans, K. | Wang, B. | +16

10

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations : Results From the Targeted Agent and Profiling Utilization Registry Study

enthalten in: JCO precision oncology | 2024

von Calfa, C. | Rothe, M. | Mangat, P. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[41]